Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A de Jonge

Showing results (181-190 of 286) with videos related to

Pageof 29
Sort By:
Nature Reviews. Microbiology|August 15, 2018
Targeting mechanisms of tailed bacteriophagesFranklin L Nobrega, Marnix Vlot, Patrick A de Jonge, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|January 1, 1985
Interference of enantiomers of lofexidine with alpha-adrenoceptorsB Wilffert, M J Mathy, H D Batink, et al.
Journal of Virology|September 17, 2020
Development of Styrene Maleic Acid Lipid Particles as a Tool for Studies of Phage-Host InteractionsPatrick A de Jonge, Dieuwke J C Smit Sibinga, Oliver A Boright, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1982
Effect of converting enzyme inhibition and angiotensin receptor blockade on the vasoconstriction mediated by alpha 1-and alpha 2-adrenoceptor stimulation in pithed normotensive ratsA de Jonge, J T Knape, J C van Meel, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1983
Differential effect of calcium entry blockers on alpha 1-adrenoceptor-mediated vasoconstriction in vivoP B Timmermans, M J Mathy, B Wilffert, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 1, 1984
Lack of relationship between intrinsic activity and susceptibility of pressor responses to blockade by nifedipine among the alpha 2-adrenoceptor agonists B-HT 920 and B-HT 958B Wilffert, P N van Heiningen, M J Mathy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2014
Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II studyP Schöffski, B Besse, T Gauler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumorsMaja J A de Jonge, Ate van der Gaast, André S T Planting, et al.
European Journal of Cancer (Oxford, England : 1990)|July 4, 2006
Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumoursM J A de Jonge, H Dumez, J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2004
Real-time pharmacokinetics guiding clinical decisions; phase I study of a weekly schedule of liposome encapsulated paclitaxel in patients with solid tumoursO Soepenberg, A Sparreboom, M J A de Jonge, et al.
Pageof 29

Showing results (181-190 of 286) with videos related to

Sort By:
Pageof 29
Nature Reviews. Microbiology|August 15, 2018
Targeting mechanisms of tailed bacteriophagesFranklin L Nobrega, Marnix Vlot, Patrick A de Jonge, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|January 1, 1985
Interference of enantiomers of lofexidine with alpha-adrenoceptorsB Wilffert, M J Mathy, H D Batink, et al.
Journal of Virology|September 17, 2020
Development of Styrene Maleic Acid Lipid Particles as a Tool for Studies of Phage-Host InteractionsPatrick A de Jonge, Dieuwke J C Smit Sibinga, Oliver A Boright, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1982
Effect of converting enzyme inhibition and angiotensin receptor blockade on the vasoconstriction mediated by alpha 1-and alpha 2-adrenoceptor stimulation in pithed normotensive ratsA de Jonge, J T Knape, J C van Meel, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1983
Differential effect of calcium entry blockers on alpha 1-adrenoceptor-mediated vasoconstriction in vivoP B Timmermans, M J Mathy, B Wilffert, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 1, 1984
Lack of relationship between intrinsic activity and susceptibility of pressor responses to blockade by nifedipine among the alpha 2-adrenoceptor agonists B-HT 920 and B-HT 958B Wilffert, P N van Heiningen, M J Mathy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2014
Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II studyP Schöffski, B Besse, T Gauler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumorsMaja J A de Jonge, Ate van der Gaast, André S T Planting, et al.
European Journal of Cancer (Oxford, England : 1990)|July 4, 2006
Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumoursM J A de Jonge, H Dumez, J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2004
Real-time pharmacokinetics guiding clinical decisions; phase I study of a weekly schedule of liposome encapsulated paclitaxel in patients with solid tumoursO Soepenberg, A Sparreboom, M J A de Jonge, et al.
Pageof 29